In continuation of our search for anti-inflammatory constituents in lipophilic extracts of Isatis tinctoria, an HPLC-based profiling for inhibitors of human neutrophil elastase was performed. Using a linear gradient profile, fractions with significant activity (>50%) appeared in the second half of the chromatogram and corresponded to moderately to highly lipophilic constituents. The active fractions of intermediate polarity were further analyzed by HPLC, TLC and GC. They contained mainly α-linolenic, linoleic, cis-11-octadecenoic acid, oleic and palmitic acids.
Our interest in woad was spurred by its purported anti-inflammatory properties for which we obtained first, in vitro evidence in a broad-based pharmacological screening involving more than 20 clinically relevant targets [4] . Subsequently, we identified the alkaloid tryptanthrin as a potent inhibitor of COX-2 and 5-LOX catalyzed eicosanoid synthesis [5, 6] , and an indolin-2-one derivative as inhibitor of histamine release from mast cells [7] . We found that the major inhibitor of 5-LOX in woad extracts was γ-linoleic acid [8] . Further anti-inflammatory activities of Isatis constituents have been reported by other groups, for example, inhibition of the expression of inducible NO synthase [9] by tryptanthrin, and inhibition of IL-6 release and TNFα by indirubin [10] . Lipophilic Isatis extracts displayed activity in various in vivo models of inflammation, cutaneous allergy and arthritis [11, 12] . In a clinical pilot study, the same extracts reduced inflammation and water loss in a cutaneous irritation model [13] .
A significant inhibition of leucocytic elastase from neutrophils had been observed in our initial in vitro screening [4] . This enzyme is one of two main proteinases of neutrophils released in connection with inflammation. It cleaves fibrous elastin, collagens, cartilage proteoglycans, and other matrix proteins. Elevated plasma levels of neutrophil elastase are a characteristic feature of an active inflammation [14, 15] . We, therefore, decided to identify the inhibitors of human neutrophil elastase in woad extracts with the aid of HPLC-based activity profiling using an established bioassay [16] . We had previously used the approach of HPLC profiling for the identification of a variety of bioactive compounds from I. tinctoria [5, 7, 8] and other plants [17] .
For HPLC profiling, the SFE extract was dissolved in dichloromethane (10 mg/mL) and separated on an analytical C-18 column. Aliquots of 200 μg extract per injection were repeatedly fractionated. A linear gradient from 10% to 100% acetonitrile over 25 min was followed by isocratic elution for an additional 20 min. In a first profiling step, 15 fractions of 3 min each (Fr. 1-15) were collected. The solvent was removed in an evaporator centrifuge and the dry films were redissolved in 180 µL DMSO for the elastase assay, which was carried out according to a published protocol [16] , whereby p-nitro-aniline release was quantified by measurements of absorbancy at 405 nm. Representative HPLC chromatograms recorded at 254 and 220 nm and the activity profile of fractions 1 to 15 in the elastase assay are shown in Figure 1 . Inhibitory activities > 50% were found in fractions 8 (77%), 9 (66%), 14 (78%) and 15 (85%). In a second step, fractions of 0.5 min were collected in the time window 21 to 30 mins, which corresponded to fractions 8 to 10. The HPLC profile of this time window and fractionation steps (8-1 to 10-6) are shown in Figure 2 .
Fractions were analyzed by HPTLC (RP-18, HOAc/H 2 O (95:5)). Upon staining with Godin's reagent, fractions 8-5, 9-2, 9-5 and 9-6 each showed one single violet spot in the R f range 0.4 to 0.5. The R f values were comparable with α-linolenic, linoleic and oleic acids. For further analysis, fractions 8-1 to 10-6 were submitted to GC after derivatization with TMSH. The results of the fatty acid analysis of the major fractions 8-5, 9-2, 9-5 and 9-6 are shown in Figure 3 . Identification was carried out by an overlay of GC chromatograms with a standard reference mix (C-18 FAME Isomer Mix, Supelco). Fraction 8-5 consisted of α-linolenic acid, fraction 9-2 of linoleic acid, whereas fraction 9-5 contained oleic acid and cis-11-octadecenoic acid in equal proportions. Fraction 9-6 consisted of palmitic acid.
Inhibition of human neutrophil elastase by saturated and unsaturated fatty acids has been recently reported. The IC 50 of α-linolenic, linoleic, oleic and palmitic acids were in the range of 5 to 15 µM [18] . Hence, inhibitory activity in fractions 8 and 9 can be attributed to these fatty acids. HPTLC and GC analysis of fractions 14 and 15, however, showed that they contained only traces of fatty acids. Elastase inhibition in these fractions seems thus due to highly lipophilic compounds, which remain to be identified.
Experimental
Organic solvents for separations were HPLC grade (Roth, Karlsruhe, Germany). HPLC grade water was obtained from a Milli-Q RG water purification system (Millipore, Schwalbach, Germany). Extracts were prepared by supercritical fluid extraction (SFE) on a pilot plant extractor, with the following conditions: CO 2 + 2000 ppm EtOH as modifier, 700 bar, 50ºC. Tryptanthrin concentration in the SFE extract was 0.23%, as determined by ESI-LC-MS. The extract was stored at -32°C. Fractionations were carried out with a HP 1100 HPLC system consisting of autosampler, highpressure mixing pump, column oven, diode array detector, and HP workstation (Agilent, Waldbronn, Germany) connected to a Gilson FC 2004 fraction collector (Gilson, Middleton, USA). GC analysis of fatty acids was carried out on a Shimadzu 17A system (Shimadzu, Duisburg, Germany) with an AOC 5000 autosampler. TLC analysis was performed on RP-18 F254 HPTLC glass plates (Merck, Darmstadt, Germany).
HPLC separations were performed on a LiChrospher 100 RP-18 cartridge (5 μm, 125 x 4 mm i.d.; Merck, Darmstadt, Germany) using acetonitrile (A) and water (B) as eluents, with the following gradient profile: 10% A (0-2 min), 10% → 100% A (2-25 min), 100% A (25-45 min). The flow rate was set at 1.0 mL/min, and the column oven was at 25°C. HPLC traces were recorded at 220 and 254 nm, and UV-vis spectra from 190-700 nm.
For activity profiling, Isatis extract was dissolved in dichloromethane at a concentration of 10 mg/mL. Aliquots of 30 μL of the solution, corresponding to 300 μg extract, were injected for HPLC separation. The column effluent was fractionated into 5 mL vials. Fifteen fractions of 3 min each were collected. The solvent was removed at 50°C in a centrifugal evaporator (Evaporator centrifuge RC 10.22, Jouan GmbH, Unterhaching, Germany). The separation was repeated 4 times. The dried films were redissolved in MeOH (500 μL), transferred into 1.5 mL Eppendorff tubes, and dried again in a centrifugal evaporator prior to shipment for bioassay. In the second round of profiling, the time window from 21 to 30 min was fractionated at higher resolution. A total of 18 fractions of 0.5 min each (8-1 to 10-6) were collected. The fractions were processed as described above.
GC analysis was carried out after derivatization with trimethylsulfoniumhydroxide (TMSH) in MeOH (Macherey-Nagel, Düren, Germany). A 2 μL volume was injected onto a capillary column, DB 225 ms (length 60 m, 0.25 mm i.d., film thickness 0.25 μm) under the following conditions: split (1:20), injector temperature 260°C, mobile phase: H 2 , (42 cm /s), detection: FID, detector temperature 270°C, temperature program: start 70 °C, hold for 2 min, 70 °C → 180°C (heating rate 10°C / min), 180°C → 220°C (heating rate 2 °C / min), hold time 5 min at 220°C, 220°C→ 230°C (heating rate 2°C / min), hold 15 min. The identification was carried out in comparison to a standard reference mix (C-18 FAME Isomer Mix, Supelco, Taufkirchen, Germany).
Plates were developed with AcOH/H 2 O (95:5) as mobile phase. Compounds were stained with Godin's reagent (equal volumes of solution A and B, freshly mixed; solution A: 1% vanillin in EtOH + 3% HClO 4 , solution B: 10% H 2 SO 4 in EtOH) followed by heating at 105°C for 3 min (Thermoplate S, Desaga, Heidelberg, Germany). The compound in fraction 8-5 showed the same chromatographic mobility and staining as the reference α-linolenic acid (violet zone, R f = 0.5), the compound in fraction 9-2 showed the same behaviour as linoleic acid (violet spot, R f = 0.45), and the spot in fractions 9-5 and 9-6 showed the same behaviour as oleic acid (pale violet staining, R f = 0.4).
Inhibition of neutrophil elastase was determined with human leucocyte elastase, according to a published procedure [16] . Briefly, 125 µL substrate solution (10 mM MeO-Suc-Ala-Ala-Pro-Val-pNA in Tris-HCl-buffer, 60 mM, pH 7.5) were mixed with 10 µL test solution (test substances solubilized in DMSO) + 445 µL Tris-HCL-buffer, pH 7.5 and vortexed. After the addition of 20 µL enzyme solution (approximately 1.05 mU) the samples were incubated for 1 h at 37°C. The reaction was stopped by addition of 500 µL soybean trypsin inhibitor solution (2 mg/mL Tris-HCl-buffer, pH 7.5) and placed in an ice bath. After vortexing, the absorbance was read at 405 nm. The assays were performed three times with duplicate samples and DMSO controls. Inhibition rates were calculated in percent to DMSO controls, and IC 50 values calculated from the dose-inhibition curves by linear regression. As positive control for the elastase assay, the inhibitor GW311616A [19] , with an IC 50 of 90 nM, was used.
For HPTLC analysis, MeOH solutions (20 µL) of fractions 8-1 to 10-6 were sprayed onto a RP-18 plate with the aid of an AS 30 TLC applicator (Desaga, Heidelberg, Germany) along with reference solutions of α-linolenic, linoleic and oleic acids (1 mg/mL).
